Reaction
Peripheral Blood Stem Cell Apheresis reporting signals
As of the last recalculation, Peripheral Blood Stem Cell Apheresis appears in 16 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is BRENTUXIMAB VEDOTIN (PRR 3,382.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Brentuximab Vedotin | 10 | 3,382.8 | 3,386.1 |
| Ifosfamide | 10 | 1,612.9 | 1,613.7 |